Drug Shortage Report for EDARBYCLOR
Report ID | 156836 |
Drug Identification Number | 02397765 |
Brand name | EDARBYCLOR |
Common or Proper name | EDARBYCLOR |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | CHLORTHALIDONE AZILSARTAN MEDOXOMIL |
Strength(s) | 25MG 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | N/A |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-03-11 |
Estimated end date | |
Actual end date | 2022-03-29 |
Shortage status | Resolved |
Updated date | 2022-04-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-03-17 | English | Compare |
v2 | 2022-03-17 | French | Compare |
v3 | 2022-04-07 | English | Compare |
v4 | 2022-04-07 | French | Compare |
v5 | 2022-04-07 | English | Compare |
v6 | 2022-04-07 | French | Compare |
Showing 1 to 6 of 6